[4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF

• 收藏
• 分享

专利权人:

Santen Pharmaceutical Co.; Ltd.

发明人:

Kenji KAWASHIMA,Yusuke YAMAZAKI,Shinji TAKAOKA,Daisuke SHII,Tomoko ODA,Takahiro MATSUYAMA

申请号：

US16532533

公开号：

US20190359577A1

申请日:

2019.08.06

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present invention relates to defined quinoxalin-2-one compounds or a pharmaceutically acceptable salt or a hydrate or a solvate thereof. The compounds, salts or hydrates have a glucocorticoid receptor agonist activity, and are useful as a medicine, in particular as a prophylactic or therapeutic agent for a glucocorticoid receptor related disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/